For more than 75% of the CLL cases analyzed, CLL B cells were either uniformly high-responders to IgM cross-linking (n = 17/105), low-responders (n = 28/105), or healthy-like with intermediate response (n = 36/105). This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.